Diagnostic Accuracy of [18F]FDG PET/MRI in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Metaanalysis

J Nucl Med. 2024 Oct 1;65(10):1533-1539. doi: 10.2967/jnumed.124.268049.

Abstract

This study evaluates the diagnostic utility of PET/MRI for primary, locoregional, and nodal head and neck squamous cell carcinoma (HNSCC) through systematic review and metaanalysis. Methods: A systematic search was conducted using PubMed and Scopus to identify studies on the diagnostic accuracy of PET/MRI for HNSCC. The search included specific terms and excluded nonhybrid PET/MRI studies, and those with a sample size of fewer than 10 patients were excluded. Results: In total, 15 studies encompassing 638 patients were found addressing the diagnostic test accuracy for PET/MRI within the chosen subject domain. Squamous cell carcinoma of the nasopharynx was the most observed HNSCC subtype (n = 198). The metaanalysis included 12 studies, with pooled sensitivity and specificity values of 93% and 95% per patient for primary disease evaluation, 93% and 96% for locoregional evaluation, and 89% and 98% per lesion for nodal disease detection, respectively. An examination of a subset of studies comparing PET/MRI against PET/CT or MRI alone for evaluating nodal and locoregional HNSCC found that PET/MRI may offer slightly higher accuracy than other modalities. However, this difference was not statistically significant. Conclusion: PET/MRI has excellent potential for identifying primary, locoregional, and nodal HNSCC.

Keywords: HNSCC; PET/MRI; [18F]FDG; head and neck squamous cell carcinoma; metaanalysis.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • Fluorodeoxyglucose F18*
  • Head and Neck Neoplasms* / diagnostic imaging
  • Humans
  • Magnetic Resonance Imaging*
  • Multimodal Imaging
  • Positron-Emission Tomography*
  • Squamous Cell Carcinoma of Head and Neck* / diagnostic imaging

Substances

  • Fluorodeoxyglucose F18